Fertility and Sterility
Volume 92, Issue 3 , Pages 979-990 , September 2009

Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f®): long-term treatment in azoospermic men with hypogonadotropic hypogonadism

  • Alvin M. Matsumoto, M.D.

      Affiliations

    • Department of Medicine, University of Washington School of Medicine, Seattle, Washington
    • Geriatric Research, Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, Washington
    • ,
  • Peter J. Snyder, M.D.

      Affiliations

    • University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • Shalender Bhasin, M.D.

      Affiliations

    • Department of Medicine, Boston University, Boston, Massachusetts
    • Current address: Department of Endocrinology, Nutrition, and Diabetes, Boston, Medical Center, Boston, MA. Study patients were enrolled at Harbor-UCLA Medical Center, Torrance, CA.
    • ,
  • Kathryn Martin, M.D.

      Affiliations

    • Reproductive Endocrinology, Massachusetts General Hospital, Boston, Massachusetts
    • ,
  • Thomas Weber, M.D.

      Affiliations

    • Department of Medicine, Division of Endocrinology, Duke University Medical Center, Durham, North Carolina
    • ,
  • Stephen Winters, M.D.

      Affiliations

    • Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
    • Current address: Division of Endocrinology, Metabolism and Diabetes, University of Louisville, KY.
    • ,
  • Daniel Spratt, M.D.

      Affiliations

    • Division of Reproductive Endocrinology and Infertility, Maine Medical Center and Maine Medical Center Research Institute, Portland, Maine
    • ,
  • Jim Brentzel, B.S.

      Affiliations

    • Clinical Development, EMD Serono, Inc., Rockland, Massachusetts
    • Corresponding Author InformationReprint requests: Jim Brentzel, B.S., EMD Serono, Inc., One Technology Place, Rockland, MA 02370 (FAX: 781-681-2901).
    • ,
  • Louis O'Dea, M.D.

      Affiliations

    • Radius Health, Inc., Cambridge, Massachusetts

Received 26 March 2008 ,Revised 23 June 2008 ,Accepted 15 July 2008.

References 

  1. Jones JR, Kemmann E. Olfacto-genital dysplasia in the female. Obstet Gynecol. 1976;5:443–446
  2. Silveira LFG, MacColl GS, Bouloux PMG. Hypogonadotropic hypogonadism. Semin Reprod Med. 2002;20:327–338
  3. Spratt DI, Carr DB, Merriam GR, Scully RE, Rao PN, Crowley WF. The spectrum of abnormal patterns of gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: clinical and laboratory correlations. J Clin Endocrinol Metab. 1987;64:283–291
  4. Bardin CW, Ross GT, Rifkin AB, Cargille CM, Lipsett MB. Studies of the pituitary–Leydig cell axis in young men with hypogonadotropic hypogonadism and hyposmia: comparison with normal men, prepubertal boys and hypopituitary patients. J Clin Invest. 1969;48:2046–2056
  5. McClure RD. Endocrine investigation and therapy. Urol Clin North Am. 1987;14:471–488
  6. Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WF. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med. 1987;106:354–361
  7. Finkel DM, Phillips JL, Snyder PJ. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med. 1985;313:651–655
  8. Saal W, Happ J, Cordes U, Baum RP, Schmidt M. Subcutaneous gonadotropin therapy in male patients with hypogonadotropic hypogonadism. Fertil Steril. 1991;56:319–324
  9. Schopohl J, Mehltretter G, Von Zumbusch R, Eversmann T, Von Werder K. Comparison of gonadotropin-releasing hormone and gonadotropin therapy in male patients with idiopathic hypothalamic hypogonadism. Fertil Steril. 1991;56:1143–1150
  10. Okada Y, Kondo T, Okamoto S, Ogawa M. Induction of ovulation and spermatogenesis by rMG/hCG in hypogonadotropic GH-deficient patients. Endocr J. 1992;39:31–43
  11. Kirk JM, Savage MO, Grant DB, Bouloux PMG, Besser GM. Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotropic hypogonadism. Clin Endocrinol. 1994;41:57–63
  12. Kung AWC, Zhong YY, Lam KSL, Wang C. Induction of spermatogenesis with gonadotrophins in Chinese men with hypogonadotrophic hypogonadism. Int J Androl. 1994;17:241–247
  13. Mastrogiacomo I, Motta RG, Botteon G, Schiesaro M. Achievement of spermatogenesis and genital tract maturation in hypogonadotropic hypogonadic subjects during long-term treatment with gonadotropins or LHRH. Andrologia. 1991;23:285–289
  14. Burgues S, Calderon MD. Subcutaneous self-administration of highly purified stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Hum Reprod. 1997;12:980–986
  15. European Metrodin HP Study Group. Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. Fertil Steril. 1998;70:256–262
  16. Liu L, Chaudhari N, Corle D, Sherins RJ. Comparison of pulsatile subcutaneous gonadotropins in the treatment of men with isolated hypogonadotropic hypogonadism. Fertil Steril. 1988;49:302–308
  17. Burris AS, Rodbard HW, Winters SJ, Sherins RJ. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J Clin Endocrinol Metab. 1988;66:1144–1151
  18. Pitteloud N, Hayes FJ, Dwyer A, Boepple PA, Lee H, Crowley WF. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2002;87:4128–4136
  19. Barkan AL, Reame NE, Kelch RP, Marshall JC. Idiopathic hypogonadotrophic hypogonadism in men: dependence of the hormone responses to gonadotropin-releasing hormone (GnRH) on the magnitude of the endogenous GnRH secretory defect. J Clin Endocrinol Metab. 1985;61:1118–1125
  20. Warne DW, Decosterd G, Okada H, Yano Y, Koide N, Howles CM. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Submitted to Fertil Steril. 2008;
  21. Burris AS, Clark RV, Vantman DJ, Sherins RJ. A low sperm concentration does not preclude fertility in men with isolated hypogonadotropic hypogonadism after gonadotropin therapy. Fertil Steril. 1988;50:343–347
  22. Büchter D, Behre HM, Kliesch S, Nieschlag E. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol. 1998;139:298–303
  23. Kliesch S, Behre HM, Nieschlag E. Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male. Fertil Steril. 1995;63:1326–1328
  24. Bouloux PMG, Nieschlag E, Burger HG, Skakkebaek NE, Wu FC, Handelsman DJ, et al. Induction of spermatogenesis by recombinant follicle-stimulating hormone (Puregon®) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone. J Androl. 2003;24:604–611
  25. Bouloux P, Warne DW, Loumaye E. Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism. Fertil Steril. 2002;77:270–273
  26. Liu PY, Turner L, Rushford D, et al. Efficacy and safety of recombinant human follicle stimulating hormone (GONAL-f®) with urinary human chorionic gonadotropin for induction of spermatogenesis and fertility in gonadotropin-deficient men. Hum Reprod. 1999;14:1540–1545
  27. World Health Organization. Laboratory manual for the examination of human semen and sperm–cervical mucus interaction. 3rd ed.. Cambridge: Cambridge University Press; 1992;
  28. Zachmann M, Prader A, Kind HP. Testicular volume during adolescence: cross sectional and longitudinal studies. Helv Paediatr Acta. 1974;29:61–72
  29. Okada H, O'Dea L, Decosterd G, Warne D Japanese Male Hypogonadotropic Hypogonadism Study Group. Combination therapy with recombinant human follicle-stimulating hormone (follitropin alfa; Gonalef®) and human chorionic gonadotropin is effective and well tolerated in azoospemic Japanese men with hypogonadotropic hypogonadism. Clin Endocrinol Jpn. 2006;54:87–94
  30. Ley SB, Leonard JM. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens. J Clin Endocrinol Metab. 1985;61:746–752
  31. Lunenfeld B, Mor A, Mani M. Treatment of male infertility. I. Human gonadotropins. Fertil Steril. 1967;18:581–592
  32. Young J, Couzinet B, Chanson P, Brailly S, Loumaye E, Schaison G. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of sertoli and leydig cell secretions and interactions. J Clin Endocrin Metab. 2000;85:3239–3244
  33. Winters SJ, Troen P. Testosterone and estradiol are co-secreted episodically by the human testis. J Clin Invest. 1986;78:870–873
  34. Santen RJ. The testis: function and dysfunction. In:  Yen SSC,  Jaffe RB,  Barbieri RL editor. Reproductive endocrinology: physiology, pathophysiology and clinical management. Philadelphia, PA: W.B. Saunders Company; 1999;p. 632–668

 A.M.M. has received consultation fees and research funding from a number of pharmaceutical companies including GSK and Solvay Pharmaceuticals. P.J.S. has nothing to disclose. S.B. has received a research grant from Solvay Pharmaceuticals and study materials supplied by Auxilium. K.M. is the Senior Deputy Editor of a scientific journal. T.W. has nothing to disclose. S.W. has nothing to disclose. D.S. has nothing to disclose. J.B. is currently employed by EMD Serono, Inc. L.O. was previously employed by EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany.

 Supported by EMD Serono, Inc., Rockland, Massachusetts, USA.

PII: S0015-0282(08)03261-5

doi: 10.1016/j.fertnstert.2008.07.1742

Fertility and Sterility
Volume 92, Issue 3 , Pages 979-990 , September 2009

Article Tools

* Image Usage & Resolution